[BHVN] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[BHVN] Biohaven Pharmaceutical Holding Company Ltd.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -13.53%
YoY- -48.98%
Quarter Report
BHVN's Result
BHVN's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 0 0 0 0 -215,079 -
PBT -319,594 -178,935 -145,968 -105,861 -88,169 -69,553 -215,250 30.17%
Tax 177 569 -1,212 -3,287 2,177 939 -14,143 -
NP -319,771 -179,504 -144,756 -102,574 -90,346 -70,492 -201,107 36.26%
Tax Rate - - - - - - - -
Total Cost 319,771 179,504 144,756 102,574 90,346 70,492 -13,972 -
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 93.50 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -3.64 -2.20 -1.81 -1.50 -1.32 -1.03 -3.30 6.76%
EPS Diluted -3.64 -2.20 -1.81 -1.50 -1.32 -1.03 -3.30 6.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.